Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noga Kurman

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Cancers|May 13, 2023
The Role of Radiation Therapy in the Treatment of Non-Melanoma Skin CancerEyal Yosefof, Noga Kurman, Dan Yaniv
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2025
The Administration of Cetuximab-Based Regimen as a Second Line After Pembrolizumab Among Incurable Head and Neck Squamous Cell Carcinoma PatientsNoga Kurman, Ido Even-Tov, Ofir Zavdy, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|April 4, 2024
Post-radiation middle ear effusion in NPC patients: Analysis of patient, tumour, and radiation factorsIgor Vainer, Sharon Tzelnick, Noga Kurman, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|April 25, 2025
Reappraising the TNM staging system for oral cavity squamous cell carcinoma: an age-related prognosis analysisAmit Ritter, Eyal Yosefof, Nofar Edri, et al.
Head & Neck|January 31, 2025
The Role of Adjuvant Radiotherapy for Early-Stage Oral Cavity Cancer With Minor Adverse Features; A Single Institute ExperienceEyal Yosefof, Nofar Edri, Noga Kurman, et al.
The Israel Medical Association Journal : IMAJ|August 16, 2022
Characterization of Fanconi Anemia Patients with Head and Neck Squamous Cell Carcinoma: Israel Fanconi RegistryNir Tsur, Omri Frig, Orna Steinberg-Shemer, et al.
Oral Oncology|June 6, 2026
Efficacy of cetuximab-based regimens after immune checkpoint inhibitor failure in recurrent or metastatic head and neck squamous cell carcinoma: a systematic review and meta-analysisTomer Boldes, Uriel Oanunu, Omri Machnes, et al.
Cancer Immunology, Immunotherapy : CII|July 5, 2025
Clinical outcomes following PD-1 inhibitor elective discontinuation in cutaneous squamous cell carcinoma: exploring treatment de-escalationItamar Averbuch, Nofar Edri, Nethanel Asher, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|August 7, 2024
Gender-Related Aspects of Laryngeal Squamous Cell Carcinoma: A Retrospective Cohort StudyNir Tsur, Elchanan Zloczower, Michal Tunik, et al.
The Laryngoscope|January 24, 2024
The Clinical Behavior and Recurrence Patterns of Oral Cavity Cancer in Oral Lichen Planus PatientsEyal Yosefof, Noga Kurman, Nofar Edri, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Cancers|May 13, 2023
The Role of Radiation Therapy in the Treatment of Non-Melanoma Skin CancerEyal Yosefof, Noga Kurman, Dan Yaniv
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2025
The Administration of Cetuximab-Based Regimen as a Second Line After Pembrolizumab Among Incurable Head and Neck Squamous Cell Carcinoma PatientsNoga Kurman, Ido Even-Tov, Ofir Zavdy, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|April 4, 2024
Post-radiation middle ear effusion in NPC patients: Analysis of patient, tumour, and radiation factorsIgor Vainer, Sharon Tzelnick, Noga Kurman, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|April 25, 2025
Reappraising the TNM staging system for oral cavity squamous cell carcinoma: an age-related prognosis analysisAmit Ritter, Eyal Yosefof, Nofar Edri, et al.
Head & Neck|January 31, 2025
The Role of Adjuvant Radiotherapy for Early-Stage Oral Cavity Cancer With Minor Adverse Features; A Single Institute ExperienceEyal Yosefof, Nofar Edri, Noga Kurman, et al.
The Israel Medical Association Journal : IMAJ|August 16, 2022
Characterization of Fanconi Anemia Patients with Head and Neck Squamous Cell Carcinoma: Israel Fanconi RegistryNir Tsur, Omri Frig, Orna Steinberg-Shemer, et al.
Oral Oncology|June 6, 2026
Efficacy of cetuximab-based regimens after immune checkpoint inhibitor failure in recurrent or metastatic head and neck squamous cell carcinoma: a systematic review and meta-analysisTomer Boldes, Uriel Oanunu, Omri Machnes, et al.
Cancer Immunology, Immunotherapy : CII|July 5, 2025
Clinical outcomes following PD-1 inhibitor elective discontinuation in cutaneous squamous cell carcinoma: exploring treatment de-escalationItamar Averbuch, Nofar Edri, Nethanel Asher, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|August 7, 2024
Gender-Related Aspects of Laryngeal Squamous Cell Carcinoma: A Retrospective Cohort StudyNir Tsur, Elchanan Zloczower, Michal Tunik, et al.
The Laryngoscope|January 24, 2024
The Clinical Behavior and Recurrence Patterns of Oral Cavity Cancer in Oral Lichen Planus PatientsEyal Yosefof, Noga Kurman, Nofar Edri, et al.
Pageof 3